Imai et al. [95] observed higher LAT1 expression in NSCLC samples without EGFR mutations, which might be associated with TKIs refractoriness and a poor prognosis in combination of LAT1 expression and EGFR wild-type. The gene discussed is SLC7A5; the disease is non-small cell lung carcinoma.